INCR vs. TEVA
Compare and contrast key facts about INC Research Holdings Inc (INCR) and Teva Pharmaceutical Industries Limited (TEVA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: INCR or TEVA.
Key characteristics
| INCR | TEVA | |
|---|---|---|
| YTD Return | 42.66% | 70.98% |
| 1Y Return | 8.24% | 69.35% |
| 3Y Return (Ann) | -36.92% | 25.84% |
| 5Y Return (Ann) | -28.14% | 18.92% |
| Sharpe Ratio | 0.11 | 1.96 |
| Daily Std Dev | 78.62% | 34.91% |
| Max Drawdown | -94.32% | -93.11% |
| Current Drawdown | -89.66% | -73.35% |
Fundamentals
| INCR | TEVA | |
|---|---|---|
| Market Cap | $84.21M | $20.22B |
| EPS | -$0.39 | -$0.39 |
| Total Revenue (TTM) | $73.47M | $16.30B |
| Gross Profit (TTM) | $18.16M | $8.07B |
| EBITDA (TTM) | -$4.60M | $4.50B |
Correlation
The correlation between INCR and TEVA is 0.10, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
INCR vs. TEVA - Performance Comparison
In the year-to-date period, INCR achieves a 42.66% return, which is significantly lower than TEVA's 70.98% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
INCR vs. TEVA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for INC Research Holdings Inc (INCR) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
INCR vs. TEVA - Dividend Comparison
Neither INCR nor TEVA has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
INCR INC Research Holdings Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
TEVA Teva Pharmaceutical Industries Limited | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 4.49% | 3.75% | 2.08% | 2.37% | 3.19% |
Drawdowns
INCR vs. TEVA - Drawdown Comparison
The maximum INCR drawdown since its inception was -94.32%, roughly equal to the maximum TEVA drawdown of -93.11%. Use the drawdown chart below to compare losses from any high point for INCR and TEVA. For additional features, visit the drawdowns tool.
Volatility
INCR vs. TEVA - Volatility Comparison
INC Research Holdings Inc (INCR) has a higher volatility of 21.63% compared to Teva Pharmaceutical Industries Limited (TEVA) at 7.12%. This indicates that INCR's price experiences larger fluctuations and is considered to be riskier than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
INCR vs. TEVA - Financials Comparison
This section allows you to compare key financial metrics between INC Research Holdings Inc and Teva Pharmaceutical Industries Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities